Q32 Bio (QTTB) Current Assets (2017 - 2026)

Q32 Bio's Current Assets history runs 10 years deep, the most recent figure standing at $57.2 million for Q1 2026.

• On a quarterly basis, Current Assets fell 16.65% year-over-year to $57.2 million in Q1 2026; TTM through Mar 2026 was $57.2 million, a 16.65% decrease from a year earlier, with the FY2025 full-year figure at $55.0 million, down 32.77% from the prior year.
• Current Assets grew to $57.2 million in Q1 2026 per QTTB's latest filing, from $55.0 million in the prior quarter.
• Across five years, Current Assets topped out at $262.4 million in Q1 2022 and bottomed at $28.7 million in Q4 2023.
• The 5-year median for Current Assets is $106.6 million (2023), against an average of $119.5 million.
• Across the five-year window, Current Assets plunged 84.14% in 2023 and surged 185.13% in 2024, its largest moves.
• Year by year, Current Assets stood at $181.0 million in 2022, then plunged by 84.14% to $28.7 million in 2023, then jumped by 185.13% to $81.9 million in 2024, then plunged by 32.77% to $55.0 million in 2025, then gained by 3.91% to $57.2 million in 2026.
• Per Business Quant, the three latest QTTB Current Assets figures stand at $57.2 million (Q1 2026), $55.0 million (Q4 2025), and $50.8 million (Q3 2025).